Basics Sutro Biopharma, Inc. IPO Date: October 12, 2018 Sector: Healthcare Industry: Biotech Market Cap: $79.76M Activated in VL: True Average Daily Range Avg Daily Range: $0.28 | 3.41% Avg Daily Range (30 D): $0.08 | 9.53% Avg Daily Range (90 D): $0.07 | 6.30% Institutional Daily Volume Avg Daily Volume: .42M Avg Daily Volume (30 D): 1.59M Avg Daily Volume (90 D): 1.37M Trade Size Avg Trade Size (Sh.): 114 Avg Trade Size (Sh.) (30 D): 297 Avg Trade Size (Sh.) (90 D): 250 Institutional Trades Total Inst.Trades: 640 Avg Inst. Trade: $1.63M Avg Inst. Trade (30 D): $1.48M Avg Inst. Trade (90 D): $1.48M Avg Inst. Trade Volume: .16M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.62M Avg Closing Trade (30 D): $1.31M Avg Closing Trade (90 D): $1.31M Avg Closing Volume: 139.74K         News May 1, 2025 @ 3:01 PM New Cancer Treatments Spark Hope as Traditional Fu... Source: Prnewswire Mar 15, 2025 @ 10:40 PM Sutro Biopharma Presents Data from Dose-Optimizati... Source: Sutro Biopharma, Inc. Sep 19, 2024 @ 4:08 PM Cancer Research Sees Major Boost as New Breakthrou... Source: Prnewswire Sep 11, 2024 @ 12:00 PM Sutro Biopharma to Host Research Forum Highlightin... Source: Sutro Biopharma, Inc. May 13, 2024 @ 9:10 PM Spruce Biosciences, Inc. (SPRB) Reports Q1 Loss, T... Source: Zacks Equity Research Financials   TTM Q1 2025 Q4 2024 Basic EPS $-2.98 $-.91 $-.89 Diluted EPS $-2.98 $-.91 $-.89 Revenue $ 66.43M $ 17.4M $ 14.81M Gross Profit $ $ $ Net Income / Loss $ -245.22M $ -75.97M $ -72.44M Operating Income / Loss $ -250.38M $ -68.51M $ -65.26M Cost of Revenue $ $ $ Net Cash Flow $ 41.01M $ -84.08M $ 15.73M PE Ratio